FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for levetiracetam, updating the product's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Juvenile Myoclonic Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)